Evaluation of sodium‐glucose cotransporter 2 inhibitors for renal prognosis and mortality in diabetes patients with heart failure on diuretics
Abstract Previous studies about renal protection of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in type 2 diabetes mellitus (T2DM) patients with heart failure (HF) on diuretics were still limited. The goal of the study is to survey the efficacy of SGLT2i to reduce all‐cause mortality and rena...
Main Authors: | Yi‐Fang Weng, Chung‐Yu Chen, Shang‐Jyh Hwang, Yaw‐Bin Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1002/kjm2.12635 |
Similar Items
-
The Role of Sodium-Glucose Co-Transporter-2 Inhibitors on Diuretic Resistance in Heart Failure
by: Panagiotis Stachteas, et al.
Published: (2024-03-01) -
Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study
by: Abdulaziz Alsalem, et al.
Published: (2024-04-01) -
Sodium glucose cotransporter 2 inhibitors as diuretic adjuvants in acute decompensated heart failure: a case series
by: Matthew Griffin, et al.
Published: (2020-08-01) -
Diuretic resistance and the role of albumin in congestive heart failure
by: Carol Fernandez Hazim, et al.
Published: (2023-12-01) -
Comprehensive review of SGLT2 inhibitors’ efficacy through their diuretic mode of action in diabetic patients
by: Cesar Ernesto Lam-Chung
Published: (2023-07-01)